Vimta Labs Limited (NSE:VIMTALABS)

India flag India · Delayed Price · Currency is INR
688.40
-5.05 (-0.73%)
Aug 1, 2025, 3:29 PM IST
-0.73%
Market Cap30.64B
Revenue (ttm)3.68B
Net Income (ttm)733.68M
Shares Outn/a
EPS (ttm)16.28
PE Ratio41.76
Forward PEn/a
Dividend1.00 (0.14%)
Ex-Dividend DateMay 30, 2025
Volume8,862,756
Average Volume5,606,115
Open702.00
Previous Close693.45
Day's Range680.00 - 728.45
52-Week Range242.05 - 728.45
Beta-0.19
RSI72.66
Earnings DateJul 17, 2025

About Vimta Labs

Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufactu... [Read more]

Sector Healthcare
Founded 1984
Employees 1,315
Stock Exchange National Stock Exchange of India
Ticker Symbol VIMTALABS
Full Company Profile

Financial Performance

In 2024, Vimta Labs's revenue was 3.45 billion, an increase of 19.25% compared to the previous year's 2.90 billion. Earnings were 667.55 million, an increase of 36.76%.

Financial Statements

News

Stocks to watch on April 29: Wipro, UCO Bank, Central Bank of India, Go Digit, Avenue Supermarts, Oberoi Realty, Ultratech, Vimta Labs, RBL Bank

The Indian stock market is likely to react to a host of corporate earnings, operational updates, and sector developments on Monday, April 29. Companies such as UCO Bank, Central Bank of India, Go Digi...

3 months ago - Business Upturn

Vimta Labs Q4 FY25 profit rises 31% YoY; announces 1:1 bonus issue and new biologics R&D foray

Vimta Labs Limited reported robust financial results for the fourth quarter and financial year ended March 31, 2025, backed by strong growth in its pharmaceutical services business. Financial highligh...

3 months ago - Business Upturn

Vimta Labs shares surge 34% in past one month

Vimta Labs has been a standout performer in the stock market, with its shares surging 34% over the past month. The stock hit a 52-week high of ₹980.75 on December 6, 2024, reflecting strong investor i...

8 months ago - Business Upturn